- Home
- MDXG vs BALY Comparison
MDXG vs BALY Comparison
Compare MDXG & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- BALY
- Stock Information
- Founded
- MDXG 2006
- BALY 2004
- Country
- MDXG United States
- BALY United States
- Employees
- MDXG N/A
- BALY 10000
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- BALY Hotels/Resorts
- Sector
- MDXG Health Care
- BALY Consumer Discretionary
- Exchange
- MDXG Nasdaq
- BALY Nasdaq
- Market Cap
- MDXG 877.4M
- BALY 737.4M
- IPO Year
- MDXG N/A
- BALY N/A
- Fundamental
- Price
- MDXG $6.67
- BALY $11.01
- Analyst Decision
- MDXG Strong Buy
- BALY Hold
- Analyst Count
- MDXG 2
- BALY 7
- Target Price
- MDXG $12.50
- BALY $18.00
- AVG Volume (30 Days)
- MDXG 771.8K
- BALY 363.4K
- Earning Date
- MDXG 07-30-2025
- BALY 02-19-2025
- Dividend Yield
- MDXG N/A
- BALY N/A
- EPS Growth
- MDXG N/A
- BALY N/A
- EPS
- MDXG 0.27
- BALY N/A
- Revenue
- MDXG $352,375,000.00
- BALY $2,481,783,000.00
- Revenue This Year
- MDXG $9.55
- BALY $3.06
- Revenue Next Year
- MDXG $11.43
- BALY N/A
- P/E Ratio
- MDXG $25.11
- BALY N/A
- Revenue Growth
- MDXG 5.34
- BALY 2.80
- 52 Week Low
- MDXG $5.47
- BALY $9.74
- 52 Week High
- MDXG $10.14
- BALY $18.38
- Technical
- Relative Strength Index (RSI)
- MDXG 57.60
- BALY 54.77
- Support Level
- MDXG $5.86
- BALY $10.18
- Resistance Level
- MDXG $7.05
- BALY $11.60
- Average True Range (ATR)
- MDXG 0.24
- BALY 1.06
- MACD
- MDXG 0.11
- BALY 0.16
- Stochastic Oscillator
- MDXG 69.20
- BALY 29.81
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, and entertainment company with a portfolio of casinos and resorts and a growing omnichannel presence. It provides customers with physical and interactive entertainment and gaming experiences, including traditional casino offerings, iGaming, online bingo, sportsbook, and free-to-play (F2P) games. The company owns and operates, several casinos across the United States, one golf course in New York, one horse racetrack in Colorado, and Aspers Casino in the United Kingdom. Its Interactive International division, an interactive gaming operator concentrated in Europe, operates a lottery management and services business. The company's reportable segments are Casinos and Resorts, which derive key revenue, International Interactive and North America Interactive.